U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06934915) titled 'Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder' on April 03.
Brief Summary: The goal of this clinical trial is to learn how prednisone affects adults with autism spectrum disorder (ASD). It will also learn about the safety of prednisone. The main questions it aims to answer are:
* How does prednisone affect the core features and associated target symptoms of ASD in adults with an immune-mediated subtype of ASD?
* Is prednisone safe for autistic adults without causing too many side effects?
* Does this study warrant larger trials studying anti-inflammatory drugs in this subject population?
Resea...